Digest Network Come funziona
Network
/
Società
Ev
Non verificato

Evaxion

Di cosa scriviamo

Annunci EconomiciBiotecnologiaFinanzaPubblicità/Marketing/Media/Comunicazione

34 comunicati stampa

Guarda tutti i comunicati
27/04/2026
Biotecnologia
Annunci Economici
Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
17/04/2026
Biotecnologia
Annunci Economici
Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
17/04/2026
Biotecnologia
Annunci Economici
New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
16/04/2026
Biotecnologia
Annunci Economici
Evaxion concludes Annual General Meeting
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
07/04/2026
Biotecnologia
Annunci Economici
Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
30/03/2026
Biotecnologia
Annunci Economici
Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
19/03/2026
Biotecnologia
Annunci Economici
Notice to convene Evaxion’s Annual General Meeting
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
17/03/2026
Biotecnologia
Annunci Economici
Evaxion to present new data at AACR Annual Meeting
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
05/03/2026
Biotecnologia
Annunci Economici
Evaxion announces business update and full year 2025 financial results
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
05/03/2026
Biotecnologia
Annunci Economici
Evaxion plans to file 2025 annual report later today
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0